ישראל -
עברית -
Ministry of Health
body polish-ג'ל גרגירים
א.ל. ארמן יצור תמרוקים בעמ - שיפור מראה העור
ישראל -
עברית -
Ministry of Health
"turbines, high and slow speed handpieces including spare parts and accessories, diamond instruments, mounted stones, polishers
des - רופא שיניים
ישראל -
עברית -
Ministry of Health
קיוטקס - מסיר לק מועשר בויטמים e
רבלון (ישראל) בעמ - הסרת לאק מן הצפורניים
ישראל -
עברית -
Ministry of Health
קיוטקס - מסיר לק ללא אצטון
רבלון (ישראל) בעמ - הסרת לאק מן הצפורניים
ישראל -
עברית -
Ministry of Health
סנדוסטטין 0.1 מגמל
novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.1 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.
ישראל -
עברית -
Ministry of Health
סנדוסטטין 0.05 מגמל
novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.05 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.